Skip to main content
Caplight Logo









Glutensens

Glutensens

Private
MilanHealthcare & Life Scienceshttps://glutensens.it/

Last Round

Seed

Sep 3, 2025

Total Funding Raised

$1.36M

Company Overview

Glutensens operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Seed round in September 2025.

Glutensens is a consumer durables company that has developed a portable device for the rapid detection of gluten in food.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Glutensens Comparables

Compare Glutensens with similar companies based on industry and business-model similarity.

Glutensens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allergen Alert
84%
LEO Verification Systems
79%
Allergy Amulet
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Glutensens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 3, 2025
Pre SeedJan 31, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Glutensens Investors

Notable investors and investment history

Glutensens investors
InvestorRounds
Farming FuturePre Seed, Seed
ToSeed & PartnersPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2025

    $1.14M round led by Farming Future.

  • Jan 31, 2024

    $220K round led by Farming Future

Book a demo to see all signals

For institutional investors. Book with your work email.

Glutensens Filings

Explore SEC and related filing metadata, where available.

Glutensens filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Glutensens's valuation, stock price, and market status.

Is Glutensens a public or private company?

Glutensens is a private company.

What is the current stock price of Glutensens?

Glutensens is a private company, so its shares have no public market price. Caplight tracks Glutensens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Glutensens worth (valuation)?

Valuation information for Glutensens is not publicly available.

Can I buy Glutensens stock?

Glutensens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Glutensens's last funding round?

Glutensens's most recent funding round was Seed on September 3, 2025.

Who are the main investors in Glutensens?

Key investors in Glutensens include Farming Future.

Will Glutensens IPO soon?

No public IPO plans have been announced for Glutensens.

How can I track Glutensens secondary market activity?

Caplight tracks bids, offers, and trades in Glutensens's shares on secondary markets.

Firmographic Details

HeadquartersMilan
Year Founded2023
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?